Login
Companies $CLCS
$0.52 -$0.22 (29.81%) Close
Cell Source Inc logo

Cell Source Inc

cell-source.com

What Do They Do?

Develops cell therapies intended to help donor cells coexist with patients’ immune systems, for blood cancer treatment and potentially organ transplantation.

How Do They Make Money?

No revenue reported yet.

Who Are Their Customers?

The company plans to focus initial market entry on influential transplant centers; it also identifies centers that provide CAR-T treatments as a potential market.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support